Avorelin
Avorelin (Meterelin) is a gonadotropin releasing hormone (GnRH) agonist. Avorelin can be used of the study of prostate cancer[1].
Product Specifications
CAS Number
140703-49-7
Product Name Alternative
Meterelin; MF 6001
UNSPSC
12352209
Target
GnRH Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/avorelin.html
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@H](CO)NC([C@@H](NC([C@@H](NC([C@@H]2CCC(N2)=O)=O)CC3=CN=CN3)=O)CC4=CNC5=CC=CC=C45)=O)=O)C(N[C@@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N6[C@@H](CCC6)C(NCC)=O)=O)=O)=O)CC7=C(C)NC8=CC=CC=C78)=O
Molecular Formula
C65H85N17O12
Molecular Weight
1296.48
References & Citations
[1]Boutignon, F., et al. Protracted release of the LHRH agonist avorelin (MF 6001) from two depot formulations in dogs and men. Lett Pept Sci 4, 423-427 (1997) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog